Format

Send to

Choose Destination
See comment in PubMed Commons below
Riv Psichiatr. 2013 Mar-Apr;48(2):140-5. doi: 10.1708/1272.14038.

[Olanzapine in manic/mixed patients with or without substance abuse].

[Article in Italian]

Author information

1
Dipartimento NESMOS, II Facolà di Medicina e Chirurgia, Ospedale Sant Andrea, Sapienza Università di Roma. gabriele.sani@justmail.it

Abstract

AIM:

To evaluate the efficacy of olanzapine in patients in their manic/mixed phase with or without comorbidity with substance abuse/dependence disorder.

METHODS:

In this observational, controlled, prospective study, 60 patients with a DSM-IV-TR diagnosis of bipolar disorder, manic/mixed episode (30 patients with and 30 patient without comorbidity with a substance abuse/dependence disorder) were treated with olanzapine, evaluated at discharge, and followed-up for 8 weeks. Efficacy of olanzapine was assessed by comparing the proportion of responders (an at least 50% drop in Young Mania Rating Scale [YMRS] score from baseline) and remitters (YMRS ≤ 12 and Hamilton Depression Rating Scale [HAM-D] ≤ 8) in both groups. Craving and days of abuse/use were assessed with Visual Analogue Scale (VAS) and Time-line Follow-Back (TLFB), respectively.

RESULTS:

Differences in response and remission percentages were statistically not significant at discharge and during follow-up. A reduction of days of abuse has been observed in the drug-abuse group, while craving was only slightly decreased.

DISCUSSION:

These results suggest that olanzapine is effective in both groups and its efficacy in reducing the days of abuse appears to be independent from its action on craving.

PMID:
23748724
DOI:
10.1708/1272.14038
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Il Pensiero Scientifico Editore
    Loading ...
    Support Center